| Primary |
| Drug Use For Unknown Indication |
66.7% |
| Depression |
33.3% |
|
| Transaminases Increased |
50.0% |
| Dermatitis Allergic |
12.5% |
| Loss Of Consciousness |
12.5% |
| Nausea |
12.5% |
| Restless Legs Syndrome |
12.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
49.0% |
| Depression |
17.2% |
| Bipolar I Disorder |
7.0% |
| Schizophrenia, Residual Type |
4.5% |
| Hepatitis C |
3.8% |
| Aspergillosis |
2.5% |
| Bipolar Disorder |
1.9% |
| Dementia Alzheimer's Type |
1.9% |
| Prophylaxis |
1.9% |
| Diuretic Therapy |
1.3% |
| Mental Disorder |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Schizoaffective Disorder |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Analgesia |
0.6% |
| Antiplatelet Therapy |
0.6% |
| Anxiety Disorder |
0.6% |
| Back Pain |
0.6% |
| Benign Prostatic Hyperplasia |
0.6% |
| Convulsion |
0.6% |
|
| Transaminases Increased |
17.3% |
| Suicide Attempt |
10.7% |
| Kidney Duplex |
9.3% |
| Hypertensive Crisis |
8.0% |
| Hypotension |
6.7% |
| Respiratory Arrest |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Muscle Rigidity |
4.0% |
| Respiratory Disorder |
4.0% |
| Completed Suicide |
2.7% |
| Death |
2.7% |
| Depressive Delusion |
2.7% |
| Dermatitis Allergic |
2.7% |
| Hepatitis Acute |
2.7% |
| Leukopenia |
2.7% |
| Loss Of Consciousness |
2.7% |
| Overdose |
2.7% |
| Restless Legs Syndrome |
2.7% |
| Rhabdomyolysis |
2.7% |
| Thrombocytopenia |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Hypertension |
12.9% |
| Drug Use For Unknown Indication |
11.3% |
| Depression |
8.2% |
| Prophylaxis |
6.1% |
| Parkinson's Disease |
5.5% |
| Crohn's Disease |
5.4% |
| Anaesthesia |
4.8% |
| Epilepsy |
4.3% |
| Bradycardia |
2.1% |
| Diarrhoea |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
| Agitation |
1.6% |
| Diabetes Mellitus |
1.6% |
| Pain Prophylaxis |
1.6% |
| Restlessness |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Glioblastoma Multiforme |
1.4% |
| Hypothyroidism |
1.4% |
| Pain |
1.4% |
|
| Urinary Tract Infection |
12.3% |
| Hyperprolactinaemia |
8.2% |
| Pulmonary Embolism |
8.2% |
| Ileus |
6.8% |
| Off Label Use |
6.8% |
| Tremor |
6.8% |
| Uterine Leiomyoma |
5.5% |
| Epistaxis |
4.1% |
| Memory Impairment |
4.1% |
| Panic Attack |
4.1% |
| Somnolence |
4.1% |
| Suicide Attempt |
4.1% |
| Tachyarrhythmia |
4.1% |
| Vanishing Bile Duct Syndrome |
4.1% |
| Cerebral Infarction |
2.7% |
| Conduction Disorder |
2.7% |
| Death |
2.7% |
| Dermatitis Allergic |
2.7% |
| Fatigue |
2.7% |
| General Physical Health Deterioration |
2.7% |
|
| Interacting |
| Depression |
70.3% |
| Hypertension |
16.2% |
| Drug Use For Unknown Indication |
10.8% |
| Convulsion |
2.7% |
|
| Urinary Retention |
37.5% |
| Syncope |
18.8% |
| Hepatotoxicity |
12.5% |
| Somnolence |
12.5% |
| Hypotension |
6.3% |
| Restlessness |
6.3% |
| Ventricular Fibrillation |
6.3% |
|
